Drugs / Paragon Novel Metabolic Regulator
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07627815 | May → Aug 2026 overdue | long COVID-19 | ParagonClinicals Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Paragon Novel Metabolic Regulator | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07627815 ↗ |
| Known as | PNMR | “Paragon Novel Metabolic Regulator (PNMR)” NCT07627815 ↗ |